SG28591G - Retrovirus of the type hiv-2 capable of inducing aids,and the antigenic and nucleic acid components thereof - Google Patents
Retrovirus of the type hiv-2 capable of inducing aids,and the antigenic and nucleic acid components thereofInfo
- Publication number
- SG28591G SG28591G SG285/91A SG28591A SG28591G SG 28591 G SG28591 G SG 28591G SG 285/91 A SG285/91 A SG 285/91A SG 28591 A SG28591 A SG 28591A SG 28591 G SG28591 G SG 28591G
- Authority
- SG
- Singapore
- Prior art keywords
- retrovirus
- antigenic
- nucleic acid
- acid components
- type hiv
- Prior art date
Links
- 230000000890 antigenic effect Effects 0.000 title 1
- 230000001939 inductive effect Effects 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
- 241001430294 unidentified retrovirus Species 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
- G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
- G01N2333/16—HIV-1, HIV-2
- G01N2333/162—HIV-1, HIV-2 env, e.g. gp160, gp110/120, gp41, V3, peptid T, DC4-Binding site
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Wood Science & Technology (AREA)
- AIDS & HIV (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8600910A FR2593189B1 (fr) | 1986-01-22 | 1986-01-22 | Nouveau retrovirus susceptible de provoquer le sida, antigenes obtenus a partir de ce retrovirus et anticorps correspondants et leurs applications au diagnostic du sida |
FR8600911A FR2593190B1 (fr) | 1986-01-22 | 1986-01-22 | Nouveau retrovirus susceptible de provoquer le sida, antigenes obtenus a partir de ce retrovirus et anticorps correspondants et leurs applications au diagnostic du sida |
FR8601635A FR2593922B1 (fr) | 1986-02-06 | 1986-02-06 | Nouveau retrovirus susceptible de provoquer le sida, antigenes obtenus a partir de ce retrovirus et anticorps correspondants et leurs applications au diagnostic du sida |
FR8601985A FR2594229B1 (fr) | 1986-02-13 | 1986-02-13 | Nouveau retrovirus du type lav-ii susceptible de provoquer le sida, antigenes obtenus a partir de ce retrovirus et anticorps correspondants et leurs applications au diagnostic du sida |
US06/835,228 US4839288A (en) | 1986-01-22 | 1986-03-03 | Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes |
FR8603881A FR2596063B1 (fr) | 1986-03-18 | 1986-03-18 | Nouveau retrovirus susceptible de provoquer le sida, antigenes obtenus a partir de ce retrovirus et anticorps correspondants et leurs applications au diagnostic du sida |
FR8604215A FR2597500B1 (fr) | 1986-03-24 | 1986-03-24 | Nouveau retrovirus susceptible de provoquer le sida, antigenes obtenus a partir de ce retrovirus et anticorps correspondants et leurs applications au diagnostic du sida |
US91608086A | 1986-10-06 | 1986-10-06 | |
US93318486A | 1986-11-21 | 1986-11-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG28591G true SG28591G (en) | 1993-02-19 |
Family
ID=27576220
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG285/91A SG28591G (en) | 1986-01-22 | 1991-04-22 | Retrovirus of the type hiv-2 capable of inducing aids,and the antigenic and nucleic acid components thereof |
Country Status (15)
Country | Link |
---|---|
EP (2) | EP0320495B1 (pt) |
JP (7) | JP2611106B2 (pt) |
AR (1) | AR243931A1 (pt) |
AT (2) | ATE195148T1 (pt) |
AU (1) | AU601397B2 (pt) |
DE (3) | DE239425T1 (pt) |
DK (2) | DK175959B1 (pt) |
ES (1) | ES2150897T3 (pt) |
GR (3) | GR880300056T1 (pt) |
HK (1) | HK62091A (pt) |
NZ (1) | NZ219024A (pt) |
OA (1) | OA08468A (pt) |
PT (1) | PT84182B (pt) |
SG (1) | SG28591G (pt) |
WO (1) | WO1987004459A1 (pt) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0249611A4 (en) * | 1985-11-14 | 1988-04-26 | Harvard College | T-LYMPHOTROPHIC VIRUS. |
AU608294B2 (en) * | 1987-01-16 | 1991-03-28 | Institut Pasteur | Peptides having immunological properties 2-hiv-2 |
EP0750041B1 (fr) * | 1987-01-16 | 2008-12-10 | Institut Pasteur | Séquences de nucléotides de HIV-2 et SIV-1 |
JPH01502751A (ja) * | 1987-03-23 | 1989-09-21 | ハイヴァー リミテッド | 新規ワクチン類 |
SE8701765L (sv) * | 1987-04-28 | 1988-10-29 | Statens Bakteriologiska Lab | Analysmetod och medel foer denna |
US4812556A (en) * | 1987-05-18 | 1989-03-14 | Virovahl | Synthetic peptide antigen for the detection of HIV-2 infection |
FR2620030B1 (fr) * | 1987-09-07 | 1990-03-23 | Transgene Sa | Vecteur d'expression des proteines du virus hiv-2, un agent causal du sida, culture cellulaire infectee ou transformee par ce vecteur, proteines obtenues, vaccin et anticorps obtenus |
ES2054769T3 (es) * | 1987-11-16 | 1994-08-16 | Hoffmann La Roche | Polipeptidos hiv-2 recombinantes. |
US5780038A (en) * | 1987-11-16 | 1998-07-14 | Roche Diagnostic Systems, Inc. | HIV-2 envelope polypeptides |
WO1989006276A2 (en) * | 1988-01-08 | 1989-07-13 | Dpz Deutsches Primatenzentrum Gesellschaft Mbh | Hiv-2-type retroviruses of primates, vaccines, diagnostic and pharmaceutical compositions |
US6210874B1 (en) | 1988-01-27 | 2001-04-03 | Biochem Immunosystems, Inc. | Synthetic peptides and mixtures thereof for detecting HIV antibodies |
WO1989009815A1 (en) * | 1988-04-04 | 1989-10-19 | Research Corporation Technologies, Inc. | Novel virus of the hiv-2 family and methods of detection therefor |
US5208321A (en) | 1988-06-09 | 1993-05-04 | Institut Pasteur | HIV-2 transmembrane glycoprotein homodimer (GP 80) |
EP0657532B1 (en) * | 1988-06-09 | 2003-12-17 | N.V. Innogenetics S.A. | HIV-3 retrovirus strains and their use |
US6197496B1 (en) | 1988-06-09 | 2001-03-06 | Institut Pasteur | Immunological reagents and diagnostic methods for the detection of human immunodeficiency virus type 2 utilizing multimeric forms of the envelope proteins gp300, p200, and p90/80 |
EP0345559A3 (en) * | 1988-06-10 | 1990-07-11 | Abbott Laboratories | Hiv-2 variants |
ATE241014T2 (de) * | 1988-06-14 | 2003-06-15 | Qiagen Gmbh | Hiv-2 varianten |
ES2085908T3 (es) * | 1989-05-12 | 1996-06-16 | Pasteur Institut | Antigenos de la glucoproteina transmembranica de cubierta de un retrovirus humano del tipo hiv-2 (antigenos que presentan entre ellos un parentesco inmunologico). |
FR2646854A1 (fr) * | 1989-05-12 | 1990-11-16 | Pasteur Institut | Antigenes de la glycoproteine transmembranaire d'enveloppe d'un retrovirus humain du type hiv-2 antigenes presentant avec eux une parente immunologique |
EP0682951B1 (en) * | 1989-05-31 | 1997-12-17 | Institut Pasteur | Immunogenic compositions comprising a purified antigen constituted by the envelope glycoprotein of the HIV-2 EHO retrovirus |
FR2647810B1 (fr) * | 1989-06-02 | 1994-07-22 | Pasteur Institut | Amorces oligonucleotidiques pour l'amplification du genome des retrovirus du type hiv-2 et siv, et leurs applications au diagnostic in vitro des infections dues a ces virus |
FR2647809B1 (fr) * | 1989-06-02 | 1991-09-20 | Pasteur Institut | Amorces oligonucleotidiques pour l'amplification du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications au diagnostic in vitro des infections dues a ces virus |
US7022814B1 (en) | 1992-01-21 | 2006-04-04 | Institut Pasteur And Institut National De La Sante Et De La Recherche Medicale | Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2 and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses |
DE69033311T2 (de) * | 1989-06-02 | 2000-02-17 | Institut National De La Sante Et De La Recherche Medicale I.N.S.E.R.M., Paris | Nukleotid-Sequenzen des Genoms von Retroviren vom Typ HIV-1, HIV-2 und SIV, ihre Verwendungen zur Amplifikation dieser Genome und in-vitro-Diagnose dieser viralen Infektionen |
ATE164853T1 (de) * | 1990-01-16 | 1998-04-15 | Orgenics Ltd | Peptide, von virus-hiv-hüllen-glycoproteinen abstammend, deren verwendung zum nachweis einer infektion dieser viren und für die impfung gegen aids |
FR2657016B1 (fr) * | 1990-01-16 | 1995-08-25 | Clonatec Sa | Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-2, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida. |
ES2053014T5 (es) * | 1990-06-15 | 2001-02-16 | Innogenetics Nv | El retrovirus sivcpz-ant y sus usos. |
GB9108652D0 (en) * | 1991-04-23 | 1991-06-12 | Antisoma Ltd | Immunoreactive compounds |
DE4233646C2 (de) * | 1992-10-06 | 2003-10-23 | Dade Behring Marburg Gmbh | Retrovirus aus der HIV-Gruppe und dessen Verwendung |
ATE174382T1 (de) * | 1992-10-06 | 1998-12-15 | Dade Behring Marburg Gmbh | Retrovirus aus der hiv-gruppe und dessen verwendung |
DE4405810A1 (de) | 1994-02-23 | 1995-08-24 | Behringwerke Ag | Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung |
US5962665A (en) | 1997-06-16 | 1999-10-05 | Abbott Laboratories | Nucleic acid primers and probes for detecting HIV-1 and HIV-2 |
FR2767337B1 (fr) | 1997-08-14 | 2002-07-05 | Pasteur Institut | Sequences nucleiques de polypeptides exportes de mycobacteri es, vecteurs les comprenant et applications au diagnostic et a la prevention de la tuberculose |
WO2002034951A2 (en) | 2000-10-23 | 2002-05-02 | Gen-Probe Incorporated | Compositions and methods for detecting human immunodeficiency virus 2 (hiv-2) |
JP4699384B2 (ja) | 2003-12-19 | 2011-06-08 | ジェン−プロウブ インコーポレイテッド | Hiv−1およびhiv−2の核酸を検出するための組成物、方法およびキット |
JP6721772B1 (ja) | 2019-03-26 | 2020-07-15 | 斉藤 幹雄 | 清掃装置 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4652599A (en) * | 1984-04-23 | 1987-03-24 | The United States Of America As Represented By The Department Of Health And Human Services | Method of continuous production of retroviruses (HTLV-III) from patients with AIDS and pre-AIDS using permissive cells |
DE3587181T2 (de) * | 1984-10-18 | 1993-06-24 | Centre Nat Rech Scient | F antigene vom menschlichen immunodefizienz-virus und deren verwendungen. |
US4600413A (en) * | 1984-12-10 | 1986-07-15 | Sundstrand Corporation | Centrifugal deaerator and pump |
JP3105581B2 (ja) * | 1991-07-03 | 2000-11-06 | 内橋エステック株式会社 | 面状温度ヒュ−ズ |
-
1987
- 1987-01-22 DE DE198787400151T patent/DE239425T1/de active Pending
- 1987-01-22 AR AR87306572A patent/AR243931A1/es active
- 1987-01-22 PT PT84182A patent/PT84182B/pt unknown
- 1987-01-22 OA OA59050A patent/OA08468A/xx unknown
- 1987-01-22 AU AU68911/87A patent/AU601397B2/en not_active Expired
- 1987-01-22 DE DE8787400151T patent/DE3760912D1/de not_active Expired
- 1987-01-22 AT AT89101328T patent/ATE195148T1/de not_active IP Right Cessation
- 1987-01-22 WO PCT/FR1987/000025 patent/WO1987004459A1/fr unknown
- 1987-01-22 AT AT87400151T patent/ATE47725T1/de not_active IP Right Cessation
- 1987-01-22 DE DE3752319T patent/DE3752319T2/de not_active Expired - Lifetime
- 1987-01-22 EP EP89101328A patent/EP0320495B1/fr not_active Expired - Lifetime
- 1987-01-22 ES ES89101328T patent/ES2150897T3/es not_active Expired - Lifetime
- 1987-01-22 NZ NZ219024A patent/NZ219024A/en unknown
- 1987-01-22 EP EP87400151A patent/EP0239425B1/fr not_active Expired
- 1987-09-21 DK DK198704934A patent/DK175959B1/da not_active IP Right Cessation
-
1988
- 1988-05-20 GR GR88300056T patent/GR880300056T1/el unknown
-
1989
- 1989-12-08 GR GR89400288T patent/GR3001096T3/el unknown
-
1991
- 1991-04-22 SG SG285/91A patent/SG28591G/en unknown
- 1991-08-08 HK HK620/91A patent/HK62091A/xx not_active IP Right Cessation
-
1993
- 1993-01-28 JP JP5012972A patent/JP2611106B2/ja not_active Expired - Lifetime
-
1994
- 1994-12-28 JP JP6329070A patent/JPH07233196A/ja active Pending
-
1995
- 1995-10-04 JP JP7257991A patent/JP2801162B2/ja not_active Expired - Lifetime
- 1995-10-25 JP JP7278085A patent/JP2735521B2/ja not_active Expired - Lifetime
-
1996
- 1996-02-21 JP JP8033969A patent/JP2874846B2/ja not_active Expired - Lifetime
- 1996-07-23 JP JP8193779A patent/JP2771519B2/ja not_active Expired - Lifetime
-
1998
- 1998-04-28 JP JP10119235A patent/JP2931294B2/ja not_active Expired - Lifetime
-
2000
- 2000-10-30 GR GR20000402397T patent/GR3034708T3/el not_active IP Right Cessation
-
2005
- 2005-02-04 DK DK200500170A patent/DK176253B1/da not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3760912D1 (en) | Retrovirus of the type hiv-2 capable of inducing aids, and the antigenic and nucleic acid components thereof | |
PL268266A1 (en) | The method of manufacture of proteins env virus aids | |
ZA853026B (en) | Leukemia-associated virus immunogen,vaccine and assay | |
EP0269712A4 (en) | PEPTIDES INVOLVED IN THE PATHOGENESIS OF A HIV TYPE INFECTION. | |
DK313188D0 (da) | 9-alfa-hydroxy-steroider, deres og de tilsvarende 9(11)-dehydro-derivaters fremstilling og laegemidler indeholdende steroiderne | |
EP0283505A4 (en) | VACCINE AND PRODUCTION METHOD. | |
EP0265457A4 (en) | VACCINE AND IMPLANT. | |
EP0245456A4 (en) | EXPRESION OF THE AIDS VIRUS GENE. | |
ZA872532B (en) | Combined vaccine | |
ZA87469B (en) | Retrovirus capable of causing aids,means and methods for detecting it in vitro | |
NO872587D0 (no) | Forbedret limpreparat og fremgangsmaate for fremstilling av dette. | |
FI873707A0 (fi) | Nya, -substituerade ketontronderivat. | |
EP0266401A4 (en) | VACCINE. | |
DE3666666D1 (en) | Early-summer meningo-encephalitis virus (fsme-virus) vaccine, and method of producing the same | |
TR23141A (tr) | Oksodiazolon tuerevi bunun hazirlanma prosesi,ve bunu ihtiva eden herbisid | |
IT8619179A0 (it) | Procedimento per la preparazione di alcansolfonil cloruri ed arilalcansolfonil cloruri. | |
DE3686396D1 (de) | Impfstoff ohne hilfsmittel. | |
DE3788424D1 (de) | Testverfahren des menschlichen b-lymphotropen virus (hblv). | |
IE870174L (en) | New retrovirus capable of causing aids, means and methods¹for detecting it in vitro | |
IE862908L (en) | Aids virus gene expression | |
GB8608991D0 (en) | Virus vaccine | |
GR3003377T3 (en) | Virus vaccine | |
ZA875294B (en) | Novel tetrahydrobenzothiazole-quinolines,their preparation and use | |
PH24810A (en) | 3-bromo-2,6-dimethoxybenzamides and the preparation thereof | |
GB8712042D0 (en) | Virus & vaccine |